You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., Oct. 1, 2014 /PRNewswire/ -- Astellas has appointed Brian McLellan as the president of Astellas Pharma Technologies in the Americas region. In this role, Brian will be responsible for managing all operations at the Norman, OK facilities. He will also be responsible for ensuring the continuous cost-effective and controlled manufacturing of products in compliance with all internal Astellas policies and all governmental regulations. McLellan will report directly to Scott Aladeen, head of the US technology division, president of Astellas US Technologies.
McLellan has been promoted to his current position from vice president of technology and operations at Astellas Pharma Technologies. He joined Yamanouchi – one of Astellas' two founding companies – in 1997 as a project manager in business development. Since then, he has held roles of increasing responsibility in the areas of manufacturing and technology. Prior to joining Astellas, McLellan worked in research & development at Shaklee U.S. Inc. He holds a bachelor's degree in management from Saint Mary's College of California.
"Brian has had great success throughout his career at Astellas and his strong leadership skills and experience in the industry will prove to be an asset to the team," said Aladeen. "Brian will be responsible for ensuring that patients who need our medications will receive the highest quality product possible."
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS.
SOURCE Astellas Pharma US, Inc.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.